Table 1. Clinical, demographic and laboratory characteristics of studied patients (n=21).
| Characteristic | Value |
|---|---|
| Age (yr) | 44.00±11.50 |
| Sex | |
| Female | 14 (66.7) |
| Male | 7 (33.3) |
| Duration of disease (mo) | 107.38±107.66 |
| PASI score | 14.43±8.44 |
| ≤10 | 9 (42.9) |
| ＞10 | 12 (57.1) |
| Total medication period (d) | 762.00±560.87 |
| CsA medication period (d) | 497.81±512.06 |
| MTX medication period (d) | 264.19±264.71 |
| CsA cumulative dose (g) | 115.68±184.34 |
| MTX cumulative dose (mg) | 448.71±448.63 |
| Underlying diseases | |
| None | 15 (71.4) |
| Diabetes | 1 (4.8) |
| Hypertension | 6 (28.6) |
| Dyslipidemia | 1 (4.8) |
| Liver disease | 0 (0) |
| Kidney disease | 0 (0) |
| Others* | 1 (4.8) |
| Laboratory abnormality | 2 (9.5) |
| CBC | 0 (0) |
| AST/ALP | 2 (9.5) |
| Uric acid | 1 (4.8) |
| BUN/Cr | 0 (0) |
| U/A | 0 (0) |
Values are presented as mean±standard deviation or number (%).
PASI: psoriasis area and severity index, CsA: cyclosporine, MTX: methotrexate, CBC: complete blood count, AST: aspartate aminotransferase, ALP: alanine aminotransferase, BUN: blood urea nitrogen, Cr: creatinine, U/A: urinalysis.
*Angina.